These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8296378)

  • 61. High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
    Schunk M; Kumma WP; Miranda IB; Osman ME; Roewer S; Alano A; Löscher T; Bienzle U; Mockenhaupt FP
    Malar J; 2006 Jul; 5():54. PubMed ID: 16817953
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chloroquine-resistant Plasmodium vivax: how common?
    Robson JM; Conroy D; Cremin JM; Hannaford R; Dunn TA
    Med J Aust; 1993 Apr; 158(7):502. PubMed ID: 8469206
    [No Abstract]   [Full Text] [Related]  

  • 63. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
    Baird JK; Basri H; Subianto B; Fryauff DJ; McElroy PD; Leksana B; Richie TL; Masbar S; Wignall FS; Hoffman SL
    J Infect Dis; 1995 Jun; 171(6):1678-82. PubMed ID: 7769318
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chloroquine-resistant Plasmodium vivax.
    Whitby M; Wood G; Veenendaal JR; Rieckmann K
    Lancet; 1989 Dec; 2(8676):1395. PubMed ID: 2574333
    [No Abstract]   [Full Text] [Related]  

  • 65. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia.
    Baird JK; Basri H; Purnomo ; Bangs MJ; Subianto B; Patchen LC; Hoffman SL
    Am J Trop Med Hyg; 1991 May; 44(5):547-52. PubMed ID: 1676566
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vivax malaria: old drug, new uses?
    Watkins B; Sibley C
    J Infect Dis; 2011 Jan; 203(2):144-5. PubMed ID: 21288811
    [No Abstract]   [Full Text] [Related]  

  • 67. Changes in glutathione metabolic enzymes in erythrocytes of Plasmodium vivax infected patients.
    Mathews ST; Selvam R
    Clin Chim Acta; 1993 Oct; 219(1-2):159-65. PubMed ID: 8306455
    [No Abstract]   [Full Text] [Related]  

  • 68. Plasmodium vivax exflagellated microgametes in human peripheral blood: a potential diagnostic dilemma.
    Camarlinghi G; Parisio EM; Nardone M; Mancini F; Ciervo A; Boccolini D; Mattei R
    New Microbiol; 2019 Oct; 42(4):231-233. PubMed ID: 31524945
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chloroquine-resistant Plasmodium vivax malaria in infancy and childhood.
    Talib VH; Kiran PC; Talib NJ; Choudhury M
    Indian J Pediatr; 1979 May; 46(376):158-62. PubMed ID: 389793
    [No Abstract]   [Full Text] [Related]  

  • 70. Mefloquine resistant P. vivax malaria in PNG.
    Amor D; Richards M
    Med J Aust; 1992 Jun; 156(12):883. PubMed ID: 1603018
    [No Abstract]   [Full Text] [Related]  

  • 71. Determination of chloroquine and desethylchloroquine in plasma and blood cells of Plasmodium vivax malaria cases using liquid chromatography.
    Dua VK; Kar PK; Gupta NC; Sharma VP
    J Pharm Biomed Anal; 1999 Oct; 21(1):199-205. PubMed ID: 10701928
    [No Abstract]   [Full Text] [Related]  

  • 72. Influence of Plasmodium vivax malaria on the relations between the osmotic stability of human erythrocyte membrane and hematological and biochemical variables.
    Mascarenhas Netto Rde C; Fabbri C; de Freitas MV; Bernardino Neto M; Garrote-Filho MS; Lacerda MV; Lima ES; Penha-Silva N
    Parasitol Res; 2014 Mar; 113(3):863-74. PubMed ID: 24322291
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Malaria in Vanuatu.
    Med J Aust; 1985 Sep; 143(6):268. PubMed ID: 3897811
    [No Abstract]   [Full Text] [Related]  

  • 74. Molecular surveillance of chloroquine resistance in Plasmodium vivax isolates from malaria cases in Yunnan Province of China using pvcrt-o gene polymorphisms.
    Ding H; Dong Y; Deng Y; Xu Y; Liu Y; Wu J; Chen M; Zhang C; Liu L; Lin Y
    Malar J; 2023 Nov; 22(1):338. PubMed ID: 37940956
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Characteristics of molecular markers associated with chloroquine resistance in Plasmodium vivax strains from vivax malaria cases in Yunnan Province, China.
    Ding H; Dong Y; Deng Y; Xu Y; Liu Y; Wu J; Chen M; Zhang C; Zheng W
    Malar J; 2023 Jun; 22(1):181. PubMed ID: 37303047
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of uncomplicated Plasmodium vivax with chloroquine plus radical cure with primaquine without G6PDd testing is safe in Arba Minch, Ethiopia: assessment of clinical and parasitological response.
    Mekonnen DA; Abadura GS; Behaksra SW; Taffese HS; Bayissa GA; Bulto MG; Tessema TS; Tadesse FG; Gadisa E
    Malar J; 2023 Apr; 22(1):135. PubMed ID: 37098510
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular Profiles of Multiple Antimalarial Drug Resistance Markers in
    Lê HG; Naw H; Kang JM; Võ TC; Myint MK; Htun ZT; Lee J; Yoo WG; Kim TS; Shin HJ; Na BK
    Microorganisms; 2022 Oct; 10(10):. PubMed ID: 36296297
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multidisciplinary Investigations of Sustained Malaria Transmission in the Greater Mekong Subregion.
    Cui L; Sattabongkot J; Aung PL; Brashear A; Cao Y; Kaewkungwal J; Khamsiriwatchara A; Kyaw MP; Lawpoolsri S; Menezes L; Miao J; Nguitragool W; Parker D; Phuanukoonnon S; Roobsoong W; Siddiqui F; Soe MT; Sriwichai P; Yang Z; Zhao Y; Zhong D
    Am J Trop Med Hyg; 2022 Oct; 107(4_Suppl):138-151. PubMed ID: 36228909
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Polymorphisms of potential drug resistant molecular markers in Plasmodium vivax from China-Myanmar border during 2008‒2017.
    Wang Z; Wei C; Pan Y; Wang Z; Ji X; Chen Q; Zhang L; Wang Z; Wang H
    Infect Dis Poverty; 2022 Apr; 11(1):43. PubMed ID: 35462549
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genetic polymorphisms in genes associated with drug resistance in Plasmodium vivax parasites from northeastern Myanmar.
    Huang F; Li S; Tian P; Pu LJS; Cui Y; Liu H; Yang L; Bi DY
    Malar J; 2022 Mar; 21(1):66. PubMed ID: 35241080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.